CNX
46
-3
PPG
47
-3
GIS
31
-3
NAVI
33
-2
FIS
50
-3
CFG
40
-12
WM
56
2
KSS
34
2
JBHT
48
-2
PNR
47
-6
MAC
40
-8
CAH
48
-2
FLR
46
-2
AON
34
-2
XYL
23
-2
IPG
35
-4
T
33
-2
GLW
46
-3
CF
56
2
MTB
41
-3
CNX
46
-3
PPG
47
-3
GIS
31
-3
NAVI
33
-2
FIS
50
-3
CFG
40
-12
WM
56
2
KSS
34
2
JBHT
48
-2
PNR
47
-6
MAC
40
-8
CAH
48
-2
FLR
46
-2
AON
34
-2
XYL
23
-2
IPG
35
-4
T
33
-2
GLW
46
-3
CF
56
2
MTB
41
-3
Financhill
Back

Phio Pharmaceuticals 10K Form

Sell
20

PHIO
Phio Pharmaceuticals

Last Price:
$1.69
Seasonality Move:
-4.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PHIO News And Ratings

See the #1 stock for the next 7 days that we like better than PHIO

PHIO Financial Statistics

Sales & Book Value

Annual Sales: $21K
Cash Flow: $-2M
Price / Cash Flow: 0
Annual Sales: $5.16
Price / Book: 0.36

Profitability

EPS (TTM): -10.91000
Net Income (TTM): $-7.4M
Gross Margin: $399K
Return on Equity: 0%
Return on Assets: 0%

Phio Pharmaceuticals Earnings Forecast

Key Phio Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 3 years for PHIO is 100.00%.
  • The Selling, General & Administrative Expenses for PHIO have been equal to 22,419.05% of Gross Profit Margin.
  • Per Share Earnings over the last 13 years have been positive in 11 years.

Phio Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PHIO
CUSIP: 71880W
Website: phiopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PHIO Technical Analysis vs Fundamental Analysis

Sell
20
Phio Pharmaceuticals (PHIO) is a Sell

Is Phio Pharmaceuticals a Buy or a Sell?